Abstract: Objectives: Extremely high concentration of folates in premature newborns: case reports. Background: Folates are a group of water soluble compounds, which are important for metabolic processes in human body. These are important during periods of rapid cell growth. The most accurate indicator of long-term folate level status in the body is the determination of red blood cell (RBC) folate concentrations. The optimal level of RBC folate is not known in neonatal period. Authors discuss the reasons for extremely high level of RBC folate concentrations. Methods: In our work we present the cases of two premature newborns with extremely high level of RBC folate concentrations, which were analyzed immunochemically on the fi rst day of life and after six weeks of life.
Abbreviations: RBC -red blood cell, NTD -neural tube defects, MTHFR -methylenetetrahydrofolate reductase, MTRR -methionine synthase reductase Folates participate in multiple different biochemical pathways and their metabolism intersects on an important step in onecarbon metabolism. Folate with choline are required in period of neurogenesis in brain and spinal cord (1) . For healthy embryonic growth the optimal folate status in cells is needed to secure optimal deoxyribonucleic acid methylation status (2) . Interference of abnormal metabolism in the pathogenesis of neural tube defects and neurological and vascular diseases has been elucidated (3) . The benefi ts of folic acid supplementation in decreasing the risk of neural tube defects (NTD) have been published (4) . Folic acid supplementation during early pregnancy was associated with a decreased risk of cleft lip (5) . There was also lower prevalence in some regions in Slovakia. The frequency of the risk rate of a birth of a child with orofacial clefts was 1 in 671 live births in Western Slovakia (6) . In comparison with the Czech Republic the overall incidence of cleft defects was 1 in 600 live births (7) . Some research has reported a reducing risk of NTD by 50-70 %, but it is a necessity to identify the genetic risk factors of NTD. Many genetic variants have been identified, but only a few of these variants have been associated with NTD risk. Only two single-nucleotide polymorphism in genes (MTHFR C677T, MTRR A66G) are considered to be risk factors for NTD (8) . The genetic polymorphisms of the MTHFR can be also associated with some neuropsychiatric disorders, such as major depressive disorders (9) .
The importance of some nutrients (folic acid, alpha tocopherol, vitamin D and polyunsaturated fatty acids) during critical stages of pregnancy is currently recognized. The exposure to epigenetic changes is responsible for altering the mechanisms of growth and metabolism and it leads to changes that may persist throughout life causing increased susceptibility to disease. Some factors before and after birth can decrease levels of stress and mental illness (10) . Important factor in prevention of cardiovascular diseases is an adequate nutrition which was recorded in reduction of hyperhomocysteinemia (11) . The risk of stable ischemic heart disease increases due to hyperhomocysteinemia. In Slovak patients, very high prevalence of hyperhomocysteinemia was detected in patients with stable ischemic heart disease (12).
Anaemia is defi ned as a hemoglobin concentration or erythrocytes mass less than 5th percentile for age. Anaemia is usually classifi ed based on the size of RBCs as measured by the mean corpuscular volume. The lack of folic acid leads to macrocytic anaemia (13) . To prevent this state, one option is folic acid supplementation.
The indication for blood transfusion in newborns is still discussed. Each hospital has its own guidelines for neonatal packed RBC transfusions. Many indications for an RBC transfusion in neonates are based on the maintenance of a specifi c hematocrit level, replacement of phlebotomy losses or treating clinical symptoms of anaemia (apnoea, tachycardia, tachypnoea and growth failure) (14) .
RBC transfusions ensure adequate tissue oxygenation during intensive care period or the treatment of clinically signifi cant symptomatic anaemia in newborns (15) . Experimental studies are essential for understanding the general mechanisms of blood transfusions. It is apparent that blood transfusions increase oxygencarrying capacity in tissues, while adequately restoring microvascular perfusion defi ciency in anaemia (16) . In human studies, it has been confi rmed that the increasing number of transfusions given in the fi rst 28 days of life remained signifi cantly associated with hypoxaemia due to chronic lung disease (17) .
Method
In this work we introduce the cases of two newborns with extremely high level of RBC folate concentrations. Their RBC folate concentrations levels were analyzed immunochemically on the fi rst day of life and after six weeks of life. Blood samples for determining RBC folate were collected in vacutainers containing EDTA and taken to the Department of Clinical Biochemistry in Hospital for Children in Bratislava. Within 24 hours of collection full blood count analysis was undertaken. The lysing agent (1.5 ml 0.2 % ascorbic acid) was added to 50 μl of whole blood for the RBC folate analysis (Roche Diagnostics, Slovakia). Immunochemical analysis was performed with the use of chemiluminescent emission (analyser cobas e 411). It was based on a competitive test using natural folate binding protein specifi c for folate. Folate competes with the added folate for the binding sites of folate binding protein labeled with ruthenium complex.
The authors inform about variable limits in different ages, especially in neonatal period in the Slovak population. There were some factors which can infl uence on RBC folate concentrations.
Results

Case report 1
The authors present the case of a male newborn who was born by caesarean section in the 27th week of gestation. Familiar history was negative. Birth weight was 900 grams and birth length was 29 centimeters. Immediately after birth he was atonic, with apnoea and acrocyanosis, but without bradycardia. The Apgar score was 5 points in the fi rst minute and 8 points in the fi fth minute after birth. During the fi rst 10 weeks of life he overcame some complications of prematurity, such as respiratory distress syndrome and apnoea. At the beginning distance therapy was performed due to respiratory distress syndrome. The newborn was without support ventilation after 24 hours of life. In laboratory fi ndings, after three weeks of life, anaemia of prematurity was recorded. This state was potentiated by sepsis. Due to this sepsis (Staphylococcus aureus) he obtained two transfusions of red blood cells according to the clinical state and laboratory tests. In the 9 th week of life the retinopathy of prematurity required diode laser retinal photocoagulation.
On the fi rst day of life the blood samples for determining RBC folate were analyzed immunochemically. The RBC folate concentration level was 1214.04 ng/ml. After six weeks of life we found extremely high RBC folate concentrations level of 5516.67 ng/ml. At the same time mild anaemia was presented (haemoblobin 9.8 g/dl; erythrocytes 3.44 x 10 12 /l; haematocrit 27.9 %). Concentration of unconjugated bilirubin was within limits of standard scale.
Case report 2
The second case was a male newborn who was born by caesarean section in the 28th week of gestation. Birth weight was 1330 grams and birth length was 30 centimeters. Mild asphyxia occurred after birth. Apgar score was 6 points in the fi rst minute and 7 points in the fi fth minute after birth. During hospitalization he suffered from some complications of prematurity. The most interesting clinical fi nding was intraventricular haemorrhage and consequently hydrocephalus with surgery solution. The complication of this diagnosis was ventriculitis with the need for transfusion. In this case we also measured RBC folate concentration levels on the fi rst day of life, which was 1306.5 ng/ml. At 2 months of life and after receiving one blood transfusion an extremely high RBC folate concentration level of 2335.1 ng/ml was recorded. At the same time anaemia was present (haemoblobin 8.6 g/dl; erythrocytes 3.3 x 10 12 /l; haematocrit 26.1 %) and the concentration of unconjugated bilirubin was within limits of standard scale.
Discussion
Accurate indicator of body saturation by folic acid is the analysis of its concentration in erythrocytes. In contrast to folic acid levels in serum, which refl ect daily changes in the body and the impact of diet, concentration of folates in erythrocytes is a refl ection of long-term processes and reserves in the body.
Erythrocyte folate levels would be expected to decline more slowly than serum folate levels over the fi rst six weeks of age in term newborns (18) .
The requirement of periconceptual supplementation with folate was already documented. Risk factors associated with birth defects of central nervous system include defi ciency of folate supplementation, cigarette smoking and exposure to x-rays (19) . Currently the supplemental dose for pregnant woman is recommended at 0.4 mg of folic acid daily (20) . The infl uence of folic acid during pregnancy on the birth weight and risk of intrauterine growth retardation and NTD were observed in some studies (4, 8, 21, 22) .
The red cell folate is the primary indicator to determine folate adequacy. Because folate is taken up only by the developing erythrocyte in the bone marrow and not by the circulating mature erythrocyte during its 120-day lifespan, erythrocyte folate concentration is an indicator of long-term status (23). Plasma folate concentration decreases markedly with age (24). It was observed in breastfed infants independent of maternal folate status that concentrations of folate decreases from birth until 24 months (25).
The normal RBC folate level is 150-600 ng/ml (26) . Also Jyothi et al. published similar results of RBC folate concentration (486-724 ng/ml) by chemiluminescent microparticle immunoassay and no defi ciency was found (<140 ng/ml) (27) . In both our cases we measured RBC folate concentration on the fi rst day of life within the limits of standard scale with our analytic methods (Roche diagnostics, analyser cobas e 411). In both cases we found extremely elevated levels in the second sample. Any other hemolyses in the body were not found, the levels of bilirubin were within the limits of standard scale.
After mandatory folic acid fortifi cation, persistent circulating unmetabolised folic acid in Irish people was reported (28) . In our fi rst case the patient was fed with formula for premature newborns with recommended daily dose of folic acid (50 μg/kg). In the second case the child was fed with maternal milk or breastfed. We did not assume the nutrition was a reason for high level of RBC folate concentrations. Hay et al, 2008 , published decreasing folates from birth until 24 months of life and positive correlation with duration of exclusive breastfeeding (25) .
In both cases the important external factor for RBC folate levels was the administration of RBC transfusion. RBC transfusion has the potential to signifi cantly infl uence tissue oxygen delivery (15) . In many neonatal units RBC transfusions are administered daily but also have strict rules. The transfusions are based on a decision, taking into account the patients' clinical status. Risks concerning "old blood" are based on the age of transfusion. "Older blood" means blood stored for about 2 weeks that can have higher potassium content which can induce arrhythmias in the neonate (14) . Other animal studies confi rmed changed microvascular perfusion, which can modulate the entrance of RBC into capillaries and RBC deformability. A signifi cant increase of chronic lung disease after repeated transfusions in preterm infants was reported (16) . Also, blood transfusions are temporally related to necrotizing enterocolitis in preterm newborns, but more prospective studies are needed (29) . However, it is a clinical observation that blood transfusions have irreplaceable benefi cial effects on patient's energy levels, exercise tolerance and positive oxygenation effect for tissues due to increased blood viscosity, improving perfusion and functional capillary density, allowing oxygen delivery by the remaining erythrocytes and fl ushing out metabolites produced during hypo-perfusion (16) .
Conclusion
RBC folate concentration is an accurate indicator of body saturation by folic acid. It is infl uenced by several factors on the mother's side (i. e. anaemia, chronic hypoxaemia due to cigarette smoking or low nutrition) as well as on the newborn's side and/or other associated complications as documented in this work. This work reported extremely high concentration levels of folate in two premature newborns after many complications of prematurity and repeated RBC transfusions. The question remains how to explain the extremely high level of folate concentration levels after RBC transfusions. Some of these reasons are high tissue oxygenation and higher risk of tissue damage due to increased oxygen affi nity and changes in functional capillary density and a high intake of micronutrients presented in RBC transfusions. Toxicity of folic acid is not a concern, as folate is water-soluble and easily excreted by kidneys when in excess; on the other hand the growing body of preterm newborn and disruption of metabolic balance could be a potential risk. The side effect of blood transfusion on extremely high level of RBC folate is not known in this area. More studies are necessary to determine this issue.
